Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Reply to C. Twelves et Al.

Partridge AH, Rumble RB, Smith IE.

J Clin Oncol. 2015 Apr 10;33(11):1301. doi: 10.1200/JCO.2014.60.2508. Epub 2015 Mar 2. No abstract available.

PMID:
25732166
2.
3.

Adjuvant and salvage radiotherapy after prostatectomy: American Society of Clinical Oncology clinical practice guideline endorsement.

Freedland SJ, Rumble RB, Finelli A, Chen RC, Slovin S, Stein MN, Mendelson DS, Wackett C, Sandler HM; American Society of Clinical Oncology.

J Clin Oncol. 2014 Dec 1;32(34):3892-8. doi: 10.1200/JCO.2014.58.8525. Epub 2014 Nov 3. Review.

4.

Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline.

Basch E, Loblaw DA, Oliver TK, Carducci M, Chen RC, Frame JN, Garrels K, Hotte S, Kattan MW, Raghavan D, Saad F, Taplin ME, Walker-Dilks C, Williams J, Winquist E, Bennett CL, Wootton T, Rumble RB, Dusetzina SB, Virgo KS.

J Clin Oncol. 2014 Oct 20;32(30):3436-48. doi: 10.1200/JCO.2013.54.8404. Epub 2014 Sep 8. Review.

PMID:
25199761
5.

Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice Guideline.

Partridge AH, Rumble RB, Carey LA, Come SE, Davidson NE, Di Leo A, Gralow J, Hortobagyi GN, Moy B, Yee D, Brundage SB, Danso MA, Wilcox M, Smith IE.

J Clin Oncol. 2014 Oct 10;32(29):3307-29. doi: 10.1200/JCO.2014.56.7479. Epub 2014 Sep 2.

PMID:
25185096
6.

Extracorporeal photopheresis in the management of graft-versus-host disease.

Bredeson C, Rumble RB, Varela NP, Kuruvilla J, Kouroukis CT; Stem Cell Transplant Steering Committee.

Curr Oncol. 2014 Apr;21(2):e310-25. doi: 10.3747/co.21.1882.

7.

Intensity-modulated radiotherapy in the treatment of head and neck cancer.

O'Sullivan B, Rumble RB, Warde P; Members of the IMRT Indications Expert Panel.

Clin Oncol (R Coll Radiol). 2012 Sep;24(7):474-87. doi: 10.1016/j.clon.2012.05.006. Epub 2012 Jul 5. Review.

PMID:
22770590
8.

Intensity-modulated radiotherapy in the treatment of breast cancer.

Dayes I, Rumble RB, Bowen J, Dixon P, Warde P; Members of the IMRT Indications Expert Panel.

Clin Oncol (R Coll Radiol). 2012 Sep;24(7):488-98. doi: 10.1016/j.clon.2012.05.003. Epub 2012 Jun 28. Review.

PMID:
22748561
9.

Intensity-modulated radiotherapy in the treatment of lung cancer.

Bezjak A, Rumble RB, Rodrigues G, Hope A, Warde P; Members of the IMRT Indications Expert Panel.

Clin Oncol (R Coll Radiol). 2012 Sep;24(7):508-20. doi: 10.1016/j.clon.2012.05.007. Epub 2012 Jun 20. Review.

PMID:
22726417
10.

Intensity-modulated radiotherapy in the treatment of gynaecological cancers.

D'Souza DP, Rumble RB, Fyles A, Yaremko B, Warde P; Members of the IMRT Indications Expert Panel.

Clin Oncol (R Coll Radiol). 2012 Sep;24(7):499-507. doi: 10.1016/j.clon.2012.05.005. Epub 2012 Jun 13. Review.

PMID:
22703725
11.

Intensity-modulated radiotherapy in the treatment of prostate cancer.

Bauman G, Rumble RB, Chen J, Loblaw A, Warde P; Members of the IMRT Indications Expert Panel.

Clin Oncol (R Coll Radiol). 2012 Sep;24(7):461-73. doi: 10.1016/j.clon.2012.05.002. Epub 2012 Jun 4. Review.

PMID:
22673744
12.

Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening.

Rabeneck L, Rumble RB, Thompson F, Mills M, Oleschuk C, Whibley A, Messersmith H, Lewis N.

Can J Gastroenterol. 2012 Mar;26(3):131-47. Review.

13.

Guideline for optimization of surgical and pathological quality performance for radical prostatectomy in prostate cancer management: evidentiary base.

Chin JL, Srigley J, Mayhew LA, Rumble RB, Crossley C, Hunter A, Fleshner N, Bora B, McLeod R, McNair S, Langer B, Evans A.

Can Urol Assoc J. 2010 Feb;4(1):13-25.

14.

Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review.

Welch S, Spithoff K, Rumble RB, Maroun J; Gastrointestinal Cancer Disease Site Group.

Ann Oncol. 2010 Jun;21(6):1152-62. doi: 10.1093/annonc/mdp533. Epub 2009 Nov 25. Review.

15.

Cancer Care Ontario Colonoscopy Standards: standards and evidentiary base.

Rabeneck L, Rumble RB, Axler J, Smith A, Armstrong D, Vinden C, Belliveau P, Rhodes K, Zwaal C, Mai V, Dixon P; Cancer Care Ontario's Colonoscopy Standards Expert Panel.

Can J Gastroenterol. 2007 Nov;21 Suppl D:5D-24D. Review.

16.

Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancer.

Jonker D, Rumble RB, Maroun J; Gastrointestinal Cancer Disease Site Groupof Cancer Care Ontario’s Program in Evidence-Based Care.

Curr Oncol. 2006 Oct;13(5):173-84.

17.

The role of gemcitabine in the treatment of cholangiocarcinoma and gallbladder cancer: a systematic review.

Dingle BH, Rumble RB, Brouwers MC; Cancer Care Ontario's Program in Evidence-Based Care's Gastrointestinal Cancer Disease Site Group.

Can J Gastroenterol. 2005 Dec;19(12):711-6. Review.

PMID:
16341310
18.

Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a clinical practice guideline.

Malthaner RA, Wong RK, Rumble RB, Zuraw L; Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care.

BMC Cancer. 2004 Sep 24;4:67. Review.

19.

Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis.

Malthaner RA, Wong RK, Rumble RB, Zuraw L; Members of the Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care.

BMC Med. 2004 Sep 24;2:35. Review.

20.

The use of preoperative radiotherapy in the management of patients with clinically resectable rectal cancer: a practice guideline.

Figueredo A, Zuraw L, Wong RK, Agboola O, Rumble RB, Tandan V; Cancer Care Ontario's Program in Evidence-based Care's Gastrointestinal Cancer Disease Site Group.

BMC Med. 2003 Nov 24;1:1. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk